News Releases

BioPharmX to Report Fourth Quarter and Full Year Financial Results

Conference call scheduled for Thursday, Mar. 23 at 1:30 p.m. PT/4:30 p.m. ET

Mar 16, 2017

MENLO PARK, Calif., Mar. 16, 2017 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced that it will release its financial results for the fiscal fourth quarter ended Jan. 31, 2017 after the close of trading on Thursday, Mar. 23, 2017.  The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT/4:30 p.m. ET to discuss the financial results along with full year and recent business developments.

Individuals interested in listening to the conference call may do so by dialing (866) 652-5200 for domestic callers or (412) 317-6060 for international callers, and request to join the BioPharmX Corporation call.  To listen to a live webcast, please visit the investor relations section of the BioPharmX website at:

A replay of the call will be available beginning Mar. 23 at 3:30 p.m. PT/6:30 p.m. ET through midnight ET on Apr. 24, 2017.  To access the replay, dial (877) 344-7529 or (412) 317-0088 and reference Conference ID: 10103314.  The webcast will also be available on the BioPharmX website for 90 days following the completion of the call.

About BioPharmX® Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical company, that seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit


SOURCE BioPharmX Corporation

For further information: For further information: Nina Brauer, Senior Manager, Marketing & Communications, [email protected], (650) 889-5030, Investor Relations, [email protected]

print email rss